GENE — Genetic Technologies Limited

NASDAQ · Healthcare · Medical - Diagnostics & Research

Company fundamentals

MetricCached value
Price (USD)0.77
Market cap (USD)111,244,160
P/E-0.4
ROE (%)-184.98
Net profit margin (%)-4.97
Revenue growth (%)-25.93
Dividend yield (%)0

Price last refreshed: .

Prices refreshed every 5 minutes during US market hours. Individual quotes may be older when provider data is missing or a refresh is incomplete. Check each quote's timestamp.

About Genetic Technologies Limited

Available company fundamentals for GENE in Medical - Diagnostics & Research. Values reflect cached source data, not live executable quotes. Valory Formula, when available, is informational analysis, not investment advice.